new_0222_0130|BBIO|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0130|BBIO|1|BridgeBio Pharma Inc Total Current Assets (Quarterly) (USD)|BridgeBio Pharma Inc Cash and Short Term Investments (Quarterly) (USD)|BridgeBio Pharma Inc Inventories (Quarterly) (USD)|BridgeBio Pharma Inc Net PP&E (Quarterly) (USD)|BridgeBio Pharma Inc Goodwill and Intangibles (Quarterly) (USD)|BridgeBio Pharma Inc Total Liabilities (Quarterly) (USD)|BridgeBio Pharma Inc Total Current Liabilities (Quarterly) (USD)|BridgeBio Pharma Inc Total Long Term Liabilities (Quarterly) (USD)|BridgeBio Pharma Inc Total Deposits (Quarterly) (USD)|BridgeBio Pharma Inc Book Value (Quarterly) (USD)|BridgeBio Pharma Inc Retained Earnings (Quarterly) (USD)|BridgeBio Pharma Inc Treasury Stock (Quarterly) (USD)|BridgeBio Pharma Inc EV to Revenues|BridgeBio Pharma Inc EV to Earnings|BridgeBio Pharma Inc EV to Free Cash Flow|BridgeBio Pharma Inc EV to Assets (Quarterly)|BridgeBio Pharma Inc PS Ratio|BridgeBio Pharma Inc PE Ratio|BridgeBio Pharma Inc Price to Book Value|BridgeBio Pharma Inc PEG Ratio|BridgeBio Pharma Inc Debt to Equity Ratio|BridgeBio Pharma Inc Dividend Yield|BridgeBio Pharma Inc Shareholder Yield (TTM)|BridgeBio Pharma Inc Percent of Shares Outstanding Short|BridgeBio Pharma Inc Total Receivables (Quarterly) (USD)|BridgeBio Pharma Inc Total Payables (Quarterly) (USD)|BridgeBio Pharma Inc Total Capital Stock (Quarterly) (USD)|BridgeBio Pharma Inc Return on Invested Capital|BridgeBio Pharma Inc Quality Ratio Score|BridgeBio Pharma Inc Momentum Score|BridgeBio Pharma Inc Beta (1Y)|BridgeBio Pharma Inc Sustainable Growth Rate (TTM)|BridgeBio Pharma Inc Institutional Investor Ownership Percentage|BridgeBio Pharma Inc Average Diluted Shares Outstanding (Quarterly)|BridgeBio Pharma Inc Total Employees (Annual)|BridgeBio Pharma Inc EPS Diluted (Quarterly) (USD)|BridgeBio Pharma Inc SG&A Expense (Quarterly) (USD)|BridgeBio Pharma Inc Shares Outstanding|BridgeBio Pharma Inc Repurchase of Capital Stock (Quarterly) (USD)|BridgeBio Pharma Inc Ordinary Shares Number (Quarterly)|BridgeBio Pharma Inc Payout Ratio|BridgeBio Pharma Inc Quick Ratio (Quarterly)|BridgeBio Pharma Inc Normalized Diluted EPS (Quarterly) (USD)|BridgeBio Pharma Inc Stock Buybacks (Quarterly) (USD)|BridgeBio Pharma Inc Effective Tax Rate (TTM)|BridgeBio Pharma Inc Return on Equity|BridgeBio Pharma Inc Net Income (TTM) (USD)|BridgeBio Pharma Inc Revenue (TTM) (USD)|BridgeBio Pharma Inc Dividend Per Share (Quarterly) (USD)|BridgeBio Pharma Inc Revenue (Quarterly) (USD)|BridgeBio Pharma Inc Gross Profit (Quarterly) (USD)|BridgeBio Pharma Inc Pre-Tax Income (Quarterly) (USD)|BridgeBio Pharma Inc Net Income (Quarterly) (USD)|BridgeBio Pharma Inc Net Interest Income (Quarterly) (USD)|BridgeBio Pharma Inc Price (USD)|BridgeBio Pharma Inc Total Return Price (USD)|BridgeBio Pharma Inc Enterprise Value (USD)|BridgeBio Pharma Inc 30-Day Average Daily Volume|BridgeBio Pharma Inc 1 Year Price Returns (Daily)|BridgeBio Pharma Inc Short Interest|BridgeBio Pharma Inc PE Ratio (Forward)|BridgeBio Pharma Inc PE Ratio (Forward 1y)|BridgeBio Pharma Inc PS Ratio (Forward)|BridgeBio Pharma Inc PS Ratio (Forward 1y)|BridgeBio Pharma Inc Quarterly EPS Estimates (USD)|BridgeBio Pharma Inc Quarterly Revenue Estimates (USD)|BridgeBio Pharma Inc Quarterly EPS Surprise|BridgeBio Pharma Inc Quarterly Revenue Surprise|BridgeBio Pharma Inc Quarterly Actual EPS (USD)|BridgeBio Pharma Inc Quarterly Actual Revenue (USD)|BridgeBio Pharma Inc Revenue Estimates for Current Fiscal Year (USD)|BridgeBio Pharma Inc Revenue Estimates for Next Fiscal Year (USD)|BridgeBio Pharma Inc Price Target (USD)|BridgeBio Pharma Inc Consensus Recommendation|BridgeBio Pharma Inc Price Target Num Estimates|BridgeBio Pharma Inc EPS Estimates for Current Fiscal Year (USD)|BridgeBio Pharma Inc EPS Estimates for Next Fiscal Year (USD)|BridgeBio Pharma Inc Research and Development Expense (Quarterly) (USD)|BridgeBio Pharma Inc Reconciled Depreciation (Quarterly) (USD)|BridgeBio Pharma Inc Non-Operating Interest Expense (Quarterly) (USD)|BridgeBio Pharma Inc Land and Improvements (Quarterly) (USD)|BridgeBio Pharma Inc Buildings and Improvements (Quarterly) (USD)|BridgeBio Pharma Inc Other Properties (Quarterly) (USD)|BridgeBio Pharma Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0130|BBIO|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0130|BBIO|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|monthly|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|daily|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0130|BBIO|5|91.2727272727|91.2727272727||91.2727272727||91.2727272727|91.2727272727|91.2727272727||91.2727272727|91.2727272727|91.2857142857|1.43827160494|91.4|7.00724637681|91.375|1.43827160494||1.45248868778|1.43827160494|91.375|1.44760479042|91.4|15.2903225806|91.2857142857|91.2727272727|91.2727272727|91.4||32.2941176471|30.5263157895|91.3333333333||91.3571428571|106.833333333|91.3571428571|91.3571428571|29.1|91.4|91.2727272727|91.4|91.375|91.3571428571|91.3846153846||91.3333333333|91.2727272727|92||91.375|91.3333333333|91.3571428571|91.3571428571|91.3571428571|7.00724637681|7.00724637681|6.95683453237|6.95488721805|1.44337349398|15.2903225806|||1.44712430427|1.44712430427|91.3846153846|91.3846153846|91.375|91.25|91.375|91.375|11.55|14.1076923077|12.3684210526|5.25139664804|12.3684210526|12.4864864865|13.2898550725|91.3571428571|91.3571428571|91.3571428571|||91.2727272727|||
new_0222_0130|BBIO|6|11|11||11||11|11|11||11|11|7|162|5|138|8|162||442|162|8|668|5|62|7|11|11|5||17|19|3||14|6|14|14|30|10|11|5|8|14|13||3|11|1||8|12|14|14|14|138|138|139|133|415|62|||539|539|13|13|8|4|8|8|80|65|76|179|76|74|69|14|14|14|||11|||
new_0222_0130|BBIO|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0130|BBIO|201803||||||||||||||||||||||||||||||||||92.3301||-0.4037|8.007||||||-0.4037|||||||||-42.43|-34.156|-0.006||||||||||||||||||||||||33.831|0.026|0.007||||||
new_0222_0130|BBIO|201806||||||||||||||||||||||||||||||||||92.3301||-0.3293|10.891||||||-0.2876|-96.723||||||||-35.702|-26.551|-0.203||||||||||||||||||||||||23.892|0.042|0.205||||||
new_0222_0130|BBIO|201809||||||||||||||||||||||||||||||||||92.3301||-0.3401|10.308||||||-0.3401|-35.113||||||||-42.078|-31.401|-0.628||||||||||||||||||||||||31.148|0.077|1.156||||||
new_0222_0130|BBIO|201812|445.223|436.086||1.575||87.701|32.577|55.124||314.879|-179.444|||||||||||||||14.506|0.092|||||||92.3301||-0.4185|14.381|||120|||-0.6278|36.3|||-130.749|||||-49.241|-38.641|0.294||||||||||||||||||||||||51.202|-0.145|1.179|||1.575|||
new_0222_0130|BBIO|201903|382.473|373.027||1.882||90.915|35.472|55.443||252.141|-234.733|||||||||||||||12.344|0.1|||||||120|152|-0.5099|18.899|||120|||-0.5099||||-157.778|||||-69.436|-61.185|0.436||||||||||||||||||||||||44.853||1.671|||1.882|||
new_0222_0130|BBIO|201906|306.709|293.803||1.865||593.268|38.705|554.563||-316.119|-326.068||||-16.6972||||12.8892|||||1.397||16.065|9.949|||||||92.8933||-0.71|16.987|120.5||123.575|||-0.71||||-197.191|||||-74.334|-65.964|-0.279|27.55|27.55|3059.927|153952.2||1726396||||||||||||19.2286|41|1.7143|7|-1.6948|-1.3968|52.331||1.941|||1.865||28.37|30.48
new_0222_0130|BBIO|201909|558.155|536.053||2.984||118.833|39.858|78.975||459.758|-366.573||||-10.0696|3.3107|||5.4805||0.1632|||2.9135||10.27|0.117|||||||117.0712|210|-0.51|23.495|117.3595||117.3595||13.4491|-0.51|-366.237|||-225.77|||26.741|24.241|-60.664|-59.98|0.623|20.13|20.13|2179.8732|329133.1667||3419268|||||-0.5367||4.9748||-0.51|26.741|26.7604|19.2286|41|1.7143|7|-2.1314|-1.7656|55.278||2.113|||2.984||18.72|29
new_0222_0130|BBIO|201912|568.622|545.993||5.625||157.946|60.385|97.561||408.454|-440.031||||-18.2223|6.2457|||10.6113||0.2247|||3.2575|2.845|8.852|0.124|||||||117.8299|248|-0.62|34.972|123.6583||123.6583||9.089|-0.62||||-260.587|||13.819|13.819|-84.151|-73.458|-0.63|36.84|36.84|4153.406|421083.5||4028168|||192.4517|53.4124|-0.6258||0.93||-0.62|13.819|26.7203|89.2664|42.7143|1.7143|7|||57.485||3.04|||5.625||34.49|31.88
new_0222_0130|BBIO|202003|924.957|905.175||24.61||540.781|64.914|475.867||380.715|-531.881|75|||-11.2548|3.1763|||9.2443||1.2118|||7.5927||13.086|0.124|||||||117.8034|296|-0.78|34.262|121.3599|-75|121.3599||13.9442|-0.78|75|||-291.252|||||-104.082|-91.85|-2.069|26.67|26.67|2668.0848|1380470.8333||9214525|||156.2729|43.3714|-0.6958||-12.1076||-0.78||15.3714|101.1601|43.875|1.625|8|-2.3279|-2.3442|68.225|0.541|4.01|||24.61||31.74|35.32
new_0222_0130|BBIO|202006|861.935|840.939||26.038||579.621|92.64|486.981||265.759|-652.915|75||-10.6031|-12.0428|4.0565|||15.0009||1.7556||-8.9181|9.2339||12.835|0.125|-48.3562||8|0.7935|-144.4734||117.0121|328|-1.03|37.969|122.2513||122.2513||9.0775|-1.03|||-144.4734|-346.322|||||-136.214|-121.034|-9.82|32.61|32.61|3624.8222|878581.5|20.9121|11288605|||177.0169|49.1286|-0.7257||-41.93||-1.03||17.2889|82.2717|44.2727|1.7273|11|-2.8314|-2.6186|86.598|1.495|10.754|||26.038||31.38|29.39
new_0222_0130|BBIO|202009|745.384|710.681||25.826||571.88|75.707|496.173||163.756|-768.774|75||-10.9673|-13.8564|5.6|||28.0771||2.8817||0.7743|8.6862|8|9.839|0.125|-56.6087||5|0.3859|-119.8138||118.1681|369|-0.98|36.016|122.5424|-0.243|122.5424||9.4929|-0.98|0.243||-119.8138|-402.201|||8.127|8.127|-130.167|-115.859|-10.237|37.1|37.1|4411.0608|617116.6333|74.7555|10644224|||204.1548|56.6604|-0.8858|8.6|-10.6332|-5.5|-0.98|8.127|22.66|88.5505|45.2727|1.7273|11|-3.363|-3.1469|92.05|-1.015|10.929|||25.826||39.76|46.98
new_0222_0130|BBIO|202012|642.824|607.093||36.833||597.332|95.648|501.684||57.906|-888.755|75||-19.2867|-20.9716|12.3004|||150.8621||8.2429||-0.0543|8.7511||8.945|0.125|-63.3912||9|0.7456|-175.751||118.9927|396|-1.01|37.437|122.8494|-0.471|122.8494||6.3472|-1.01|0.471||-175.751|-448.724|||0.122|0.122|-135.025|-119.981|-10.514|67.62|67.62|8411.9521|630813.9333|102.8816|10750649|||107.655|80.0333|-0.8606|16.9303|-17.3627|-99.2794|-1.01|0.122|22.5211|82.3275|56.1111|1.6667|9|-3.4419|-3.0357|90.174|2.067|10.962|||36.833||62.33|65.94
new_0222_0130|BBIO|202103|945.114|919.118||35.813||1482.673|94.729|1387.944||-395.294|-1037.506|125||-18.5346|-21.4248|8.8146|||152.0792||-3.4527||-2.2087|7.0371|0.462|10.34|0.152|-65.8288||8|0.3119|-549.8169||138.6277||-1.18|45.407|149.1146|-51.021|149.1146||9.7075|-1.18|51.021||-549.8169|-519.953|||0.462||-171.082|-163.079|-9.344|59.12|59.12|8724.8685|1005350.0333|112.4138|10493339|||113.1961|84.1527|-0.751|20.4322|-57.128|-97.7389|-1.18|0.462|78.1388|104.4557|84.3|1.7|10|-3.165|-3.3846|122.559|1.365|9.738|||35.813||55.32|57.68
new_0222_0130|BBIO|202106|909.871|837.663||42.236||1538.976|131.909|1407.067||-464.294|-1133.854|130.308|154.0379|-19.5118|-19.9902|8.9355|126.9395|||-0.5258|-2.9591||-1.3507|7.4489|45.538|22.329|0.153|-62.6073||8|0.5376|||146.7543||-0.66|45.97|149.6147|-7.589|149.6147||6.6955|-0.66|7.589|||-495.267|62.735||54.024|53.915|-102.074|-96.348|-10.516|60.12|60.12|9426.6221|1050216.9667|86.9365|11144718|||112.3957|83.5577|-0.8924|24.9251|26.0438|116.7456|-0.66|54.024|69.4361|101.4892|80.4444|1.6|9|-3.9155|-4.054|101.96|2.687|10.839|||42.236||53.74|50.11
new_0222_0130|BBIO|202109|639.71|599.611||44.849|46.204|1520.365|95.823|1424.542||-743.397|-1289.789|275|134.7498|-14.3352|-16.8556|9.8196|113.3723|||-0.8175|-1.85||0.3077|7.4496|8.172|12.035|0.153|-70.4462||8|2.1029|||146.6628||-1.06|46.084|147.0879|-143.883|147.0879||6.3428|-1.06|143.883|||-535.343|56.952||2.344|0.89|-161.016|-155.935|-10.833|50.1|50.1|8046.3025|940636.1|24.92|10957509|||84.9576|63.1596|-0.9109|16.1237|-16.3659|-85.4624|-1.06|2.344|110.4413|132.4623|79.6667|1.3333|9|-3.6496|-3.8335|104.305|0.265|11.067|||44.849||49.08|40.5
new_0222_0130|BBIO|202112|||||||||||||56.8076||-5.4254||40.3467|||-0.2909||||9.8835||||||3|-0.0845||||||||||||||||||||||||13.43|13.43|2756.9549|3525100.1|-76.5434|14547801|||29.3666|42.9591|-0.9055|21.5768|||||78.2623|83.6001|32.4|1.4|10|-3.6857|-4.2008||||||||10.25|8.08
new_0222_0130|BBIO|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.0463|2.8791||||||||||||||||||||
new_0222_0130|BBIO|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.0502|3.4364||||||||||||||||||||
new_0222_0130|BBIO|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.0433|8.1022||||||||||||||||||||
new_0222_0130|BBIO|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.1166|10.8231||||||||||||||||||||